Stock Events

Stock Events

BioNTech 

$103.76
2091
+$0.88+0.86% Friday 20:00
+$0.49+0.47%Friday 23:56After hours

Statistics

Day High
104.82
Day Low
102.33
52W High
124
52W Low
79.52
Volume
612,198
Avg. Volume
1,211,247
Mkt Cap
26.06B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jun 22
$2.13
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

4AugExpected
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-3.62
-1.53
0.55
2.64
Expected EPS
-1.31
Actual EPS
-1.82

Financials

-38.69%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.35BRevenue
-1.3BNet Income

Analyst Ratings

124.64Average Price Target
The highest estimate is 140.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
82%
Hold
18%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BNTX. It's not an investment recommendation.
Apple
224
AAPL
Microsoft
222
MSFT
Amazon
199
AMZN
Tesla
191
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap55.09B
Moderna, Inc. is a direct competitor in the mRNA technology space, focusing on vaccines including COVID-19, similar to BioNTech.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc., although a partner with BioNTech on the COVID-19 vaccine, competes in the broader vaccine and biopharmaceutical market.
Novavax
NVAX
Mkt Cap1.53B
Novavax, Inc. competes in the development of vaccines for infectious diseases, including COVID-19, similar to BioNTech's main products.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson competes in the pharmaceutical and biotechnology industry, including the development of vaccines for COVID-19.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC competes in the development of vaccines and therapeutics, including their own COVID-19 vaccine.
Sanofi
SNY
Mkt Cap107.39B
Sanofi competes in the global pharmaceutical market, including the development of vaccines and collaboration on mRNA vaccine technology.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline plc competes in the pharmaceutical and healthcare industry, including vaccine development, posing competition in the vaccine market.
Arcturus Therapeutics
ARCT
Mkt Cap431.75M
Arcturus Therapeutics Holdings Inc. is involved in the development of mRNA vaccines and therapeutics, competing in the same space as BioNTech.
Incyte
INCY
Mkt Cap25.21B
Incyte Corporation competes in the biopharmaceutical field, focusing on cancer and other diseases, which overlaps with BioNTech's therapeutic areas.

About

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Show more...
CEO
Ugur Sahin
Employees
7807
Country
Germany
ISIN
US09075V1026
WKN
000A2PSR2

Listings

MX
MX
BNTXN.MX
F
DE
22UA.F
STU
DE
22UA.STU
MU
DE
22UA.MU

0 Comments

Share your thoughts

FAQ

What is BioNTech stock price today?▼
The current price of BNTX is $103.76 USD — it has increased by +0.86% in the past 24 hours. Watch BioNTech stock price performance more closely on the chart.
What is BioNTech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange BioNTech stocks are traded under the ticker BNTX.
Is BioNTech stock price growing?▼
BNTX stock has risen by +1.65% compared to the previous week, the month change is a +12.56% rise, over the last year BioNTech has showed a -7.74% decrease.
What is BioNTech market cap?▼
Today BioNTech has the market capitalization of 26.06B
What were BioNTech earnings last quarter?▼
BNTX earnings for the last quarter are -1.82 USD per share, whereas the estimation was -1.31 USD resulting in a -38.93% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BioNTech revenue for the last year?▼
BioNTech revenue for the last year amounts to 3.35B USD.
What is BioNTech net income for the last year?▼
BNTX net income for the last year is -1.3B USD.
Does BioNTech pay dividends?▼
Yes, BNTX dividends are paid en. The last dividend per share was 2.13 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does BioNTech have?▼
As of September 05, 2026, the company has 7,807 employees.
In which sector is BioNTech located?▼
BioNTech operates in the Health & Wellness sector.
When did BioNTech complete a stock split?▼
BioNTech has not had any recent stock splits.
Where is BioNTech headquartered?▼
BioNTech is headquartered in Mainz, Germany.